About ProFibrix
ProFibrix is a company based in Leiden (Netherlands) founded in 2004 was acquired by The Medicines Company in June 2013.. ProFibrix has raised $33 million across 4 funding rounds from investors including The Medicines Company, Vesalius Biocapital Partners and Index Ventures. ProFibrix operates in a competitive market with competitors including QBiotics, RevBio, MediWound, Dimension Inx and Ilya Pharma, among others.
- Headquarter Leiden, Netherlands
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33 M (USD)
in 4 rounds
-
Latest Funding Round
$10.6 M (USD), Series B
Aug 05, 2011
-
Investors
The Medicines Company
& 4 more
-
Employee Count
Employee Count
-
Acquired by
The Medicines Company
(Jun 04, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ProFibrix
ProFibrix has successfully raised a total of $33M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $10.6 million completed in August 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $10.6M
-
First Round
First Round
(27 Mar 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2011 | Amount | Series B - ProFibrix | Valuation |
investors |
|
| May, 2011 | Amount | Series B - ProFibrix | Valuation | Vesalius Biocapital Partners , Index Ventures |
|
| Aug, 2009 | Amount | Series B - ProFibrix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ProFibrix
ProFibrix has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include The Medicines Company, Vesalius Biocapital Partners and Index Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology startups and entrepreneurs.
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProFibrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ProFibrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Profibrix Comparisons
Competitors of ProFibrix
ProFibrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as QBiotics, RevBio, MediWound, Dimension Inx and Ilya Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
3D biomaterials are provided for regenerative medicine applications.
|
|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based therapeutics for cancer and immunological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ProFibrix
When was ProFibrix founded?
ProFibrix was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is ProFibrix located?
ProFibrix is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Is ProFibrix a funded company?
ProFibrix is a funded company, having raised a total of $33M across 4 funding rounds to date. The company's 1st funding round was a Series B of $11.4M, raised on Mar 27, 2007.
What does ProFibrix do?
ProFibrix used its fibrinogen technology to develop and commercialize products for the hemostasis and regenerative medicine markets. Profibrixs lead biologic Fibrocaps is a formulation of fibrinogen and thrombin to aid in hemostasis during surgery. ProFibrix was acquired by The Medicines Company in Aug 2013. Fibrocaps is now known as Raplixa and received FDA approval in April 2015.
Who are the top competitors of ProFibrix?
ProFibrix's top competitors include Ilya Pharma, RevBio and QBiotics.
Who are ProFibrix's investors?
ProFibrix has 5 investors. Key investors include The Medicines Company, Vesalius Biocapital Partners, Index Ventures, Gilde Healthcare, and Inkef.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.